Cancer incidence and mortality in Europe, 2004

被引:967
作者
Boyle, P [1 ]
Ferlay, J [1 ]
机构
[1] Int Agcy Res Canc, F-69372 Lyon, France
关键词
cancer; deaths; Europe; European Union; incidence;
D O I
10.1093/annonc/mdi098
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There are no recent estimates of the incidence and mortality from cancer at a European level. Those data that are available generally refer to the mid-1990s and are of limited use for cancer control planning. We present estimates of the cancer burden in Europe in 2004, including data for the (25 Member States) European Union. Methods: The most recent sources of incidence and mortality data available in the Descriptive Epidemiology Group at IARC were applied to population projections to derive the best estimates of the burden of cancer, in terms of incidence and mortality, for Europe in 2004. Results: In 2004 in Europe, there were an estimated 2886800 incident cases of cancer diagnosed and 1711000 cancer deaths. The most common incident form of cancer was lung cancer (13.3% of all incident cases), followed by colorectal cancer (13.2%) and breast cancer (13%). Lung cancer was also the most common cause of cancer death (341800 deaths), followed by colorectal (203700), stomach (137 900) and breast (129 900). Conclusions: With an estimated 2.9 million new cases (54% occurring in men, 46% in women) and 1.7 million deaths (56% in men, 44% in women) each year, cancer remains an important public health problem in Europe, and the ageing of the European population will cause these numbers to continue to increase even if age-specific rates remain constant. To make great progress quickly against cancer in Europe, the need is evident to make a concerted attack on the big killers: lung, colorectal, breast and stomach cancer. Stomach cancer rates are falling everywhere in Europe and public health measures are available to reduce the incidence and mortality of lung cancer, colorectal cancer and breast cancer.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 18 条
  • [1] [Anonymous], 2001, COCHRANE DB SYST REV
  • [2] [Anonymous], WHO DAT
  • [3] PROGRESS IN PREVENTING DEATH FROM COLORECTAL-CANCER
    BOYLE, P
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (03) : 528 - 530
  • [4] European Code Against Cancer and scientific justification: third version (2003)
    Boyle, P
    Autier, P
    Bartelink, H
    Baselga, J
    Boffetta, P
    Burn, J
    Burns, HJG
    Christensen, L
    Denis, L
    Dicato, M
    Diehl, V
    Doll, R
    Franceschi, S
    Gillis, CR
    Gray, N
    Griciute, L
    Hackshaw, A
    Kasler, M
    Kogevinas, M
    Kvinnsland, S
    La Vecchia, C
    Levi, F
    McVie, JG
    Maisonneuve, P
    Martin-Moreno, JM
    Bishop, JN
    Oleari, F
    Perrin, P
    Quinn, M
    Richards, M
    Ringborg, U
    Scully, C
    Siracka, E
    Storm, H
    Tubiana, M
    Tursz, T
    Veronesi, U
    Wald, N
    Weber, W
    Zaridze, DG
    Zatonski, W
    zur Hausen, H
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (07) : 973 - 1005
  • [5] Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
    Boyle, P
    d'Onofrio, A
    Maisonneuve, P
    Severi, G
    Robertson, C
    Tubiana, M
    Veronesi, U
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (08) : 1312 - 1325
  • [6] BOYLE P, 2003, TOBACCO SCI POLICY P
  • [7] Estimates of cancer incidence and mortality in Europe in 1995
    Bray, F
    Sankila, R
    Ferlay, J
    Parkin, DM
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) : 99 - 166
  • [8] Overview of the main outcomes in breast-cancer prevention trials
    Cuzick, J
    Powles, T
    Veronesi, U
    Forbes, J
    Edwards, R
    Ashley, S
    Boyle, P
    [J]. LANCET, 2003, 361 (9354) : 296 - 300
  • [9] Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study
    Faivre, J
    Dancourt, V
    Lejeune, C
    Tazi, MA
    Lamour, J
    Gerard, D
    Dassonville, F
    Bonithon-Kopp, C
    [J]. GASTROENTEROLOGY, 2004, 126 (07) : 1674 - 1680
  • [10] FERLAY J, 1999, 4 IARC